Global Market Report

Cholera Vaccines Market Report 2019-2029

Our 216-page report provides 33 tables, 80 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Cholera Vaccines market. See how to exploit the opportunities.

SKU: PHA0485 Category: Tags: , Code: PHA0485Pages: 159
Clear
← Back to category Therapeutic Drugs

Description

Cholera Vaccines , our new study reveals trends, R&D progress, and predicted revenues
Where is the Cholera Vaccines market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2029, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 216-page report provides 33 tables, 80 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Cholera Vaccines market. See how to exploit the opportunities.

Forecasts to 2029 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2029, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 2 segmentations of the Cholera Vaccines market, with forecasts for 5 Products, 6 Technologies, and 3 End Users, each forecasted at a global and regional level.

Global Cholera Vaccines Market by Product
• Reagents
• Dukoral
• Shanchol
• Vaxchora
• Euvichol & Euvichol-Plus
• Others

Global Cholera Vaccines Market by End User
• Hospitals & Clinics
• Research & Academic Laboratories
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 regional and 17 leading national markets:

• North America:
• US
• Canada

• Latin America:
• Brazil
• Mexico
• Rest of Latin America

• Western Europe:
• Germany
• The UK
• Italy
• France
• Spain
• Nordic
• Benelux
• Rest of Western Europe

• Eastern Europe:
• Russia
• Poland
• Rest of Eastern Europe

• Asia-Pacific:
• Japan
• China
• India
• Australia & New Zealand
• ASEAN
• Rest of Asia-Pacific

• MEA:
• GCC Countries
• South Africa
• Northern Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Cholera Vaccines market, with a focus on this segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, Russia, Germany and China in particular, will continue to achieve high revenue growth to 2029.

Leading companies and the potential for market growth
Overall world revenue for Cholera Vaccines will surpass $76.68 million in 2019, our work calculates. We predict strong revenue growth through to 2029.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Cholera Vaccines Market report helps you
In summary, our 253-page report provides you with the following knowledge:

• Revenue forecasts to 2029 for 7 segmentations of the Cholera Vaccines market, with forecasts for 2 Segmentations of the Cholera Vaccines market, with forecasts for 5 Products, 6 Technologies, and 3 End Users, each forecasted at a global and regional level , discover the industry’s prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2029 for 6 regional and 21 key national markets , See forecasts for the Cholera Vaccines market in North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, the UK, Italy, France, Nordic Countries, Benelux, China, India, Japan, Australia & New Zealand, ASEAN countries, GCC Countries, South Africa and Northern Africa.

• Stimulates and restrains companies and the market

• Prospects for established firms and those seeking to enter the market , including company profiles for 10 of the major companies involved in the Cholera Vaccines market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Cholera Vaccines Sequencing market and leading companies. You will find data, trends and predictions.

Get our report today The Cholera Vaccines Market Forecast 2019-2029: Revenue Prospects by Product (Dukoral, Shanchol, Vaxchora, Euvichol & Euvichol-Plus, Others), by End User (Hospitals & Clinics, Research & Academic Laboratories, Others) and Geography.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain

2. Cholera vaccines Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Global Cholera vaccines Market Size and Forecast
2.3. Market Dynamics
2.3.1. Market Drivers
2.3.1.1. Rising initiatives and awareness regarding immunization
2.3.1.2. Increasing incidences of cholera
2.3.1.3. Development of novel approaches for new cholera vaccine
2.3.2. Market Restraints
2.3.2.1. Lack of Access to Adequate Treatment
2.3.3. Market Opportunities
2.3.4. Global Cholera vaccines Market: Trends
2.3.5. Mergers and Acquisitions
2.3.6. Entry of New Market Players

3. Global Cholera vaccines Market Analysis and Forecast, By Product
3.1. Introduction
3.1.1. Global Cholera vaccines Market, Annual Growth Rate Comparison, By Product
3.2. Global Cholera vaccines Market Size and Forecast, By Product
3.2.1. Dukoral
3.2.2. Shanchol
3.2.3. Vaxchora
3.2.4. Euvichol & Euvichol-Plus
3.2.5. Others
3.3. Global Cholera vaccines Attractiveness Index, By Product

4. Global Cholera vaccines Market Analysis and Forecast, By End User
4.1. Introduction
4.1.1. Global Cholera vaccines Market, Annual Growth Rate Comparison, By End User
4.1.2. Global Cholera vaccines Market Share Comparison, By End User (2018 & 2029)
4.2. Global Cholera vaccines Market Size and Forecast, By End User
4.2.1. Hospitals & Clinics
4.2.2. Research & Academic Laboratories
4.2.3. Other segments
4.3. Global Cholera vaccines Attractiveness Index, By End Users

5. Global Cholera vaccines Market Analysis and Forecast, By Region
5.1. Introduction
5.1.1. Global Cholera vaccines Market, Annual Growth Rate Comparison, By Region
5.1.2. Global Cholera vaccines Market Share Comparison, By Region (2018 & 2029)
5.2. Global Cholera vaccines Market Size and Forecast, By Region
5.2.1. North America (U.S., Canada)
5.2.2. Latin America (Brazil, Mexico, Rest of Latin America)
5.2.3. Western Europe (UK, France, Germany, Italy, Spain, Nordic, Benelux, RoWE)
5.2.4. Eastern Europe (Russia, Poland, Rest of Eastern Europe)
5.2.5. Asia Pacific (Japan, China, India, ASEAN, Australia, RoAPAC)
5.2.6. MEA (GCC, South Africa, North Africa, RoMEA)
5.3. Global Cholera vaccines Market Attractiveness Index, By Region

6. North America Cholera vaccines Market Analysis and Forecast, 2019-2029
6.1. Introduction
6.1.1. North America Cholera vaccines Market
6.1.2. North America Cholera vaccines Market, Annual Growth Rate Comparison, By Country
6.2. North America Cholera vaccines Market Size and Forecast, By Country
6.2.1. The U.S. Cholera vaccines Market
6.2.2. Canada Cholera vaccines Market
6.3. North America Cholera vaccines Market Size and Forecast, By Product
6.4. North America Cholera vaccines Market Size and Forecast, By End User
6.5. North America Cholera vaccines Market Attractiveness Index
6.6. North America Cholera vaccines Market Attractiveness Index, By Country
6.7. North America Cholera vaccines Market Attractiveness Index, By Product
6.8. North America Cholera vaccines Market Attractiveness Index, By End User

7. Latin America Cholera vaccines Market Analysis and Forecast, 2019-2029
7.1. Introduction
7.1.1. Latin America Cholera vaccines Market
7.1.2. Latin America Cholera vaccines Market, Annual Growth Rate Comparison, By Country
7.2. Latin America Cholera vaccines Market Size and Forecast, By Country
7.2.1. Brazil Cholera vaccines Market
7.2.2. Mexico Cholera vaccines Market
7.2.3. Rest of Latin America Cholera vaccines Market
7.3. Latin America Cholera vaccines Market Size and Forecast, By Product
7.4. Latin America Cholera vaccines Market Size and Forecast, By End User
7.5. Latin America Cholera vaccines Market Attractiveness Index
7.6. Latin America Cholera vaccines Market Attractiveness Index, By Country
7.7. Latin America Cholera vaccines Market Attractiveness Index, By Product
7.8. Latin America Cholera vaccines Market Attractiveness Index, By End User

8. Western Europe Cholera vaccines Market Analysis and Forecast, 2019-2029
8.1. Introduction
8.1.1. Western Europe Cholera vaccines Market
8.1.2. Western Europe Cholera vaccines Market, Annual Growth Rate Comparison, By Country
8.2. Western Europe Cholera vaccines Market Size and Forecast, By Country
8.2.1. U.K. Cholera vaccines Market
8.2.2. France Cholera vaccines Market
8.2.3. Germany Cholera vaccines Market
8.2.4. Italy Cholera vaccines Market
8.2.5. Spain Cholera vaccines Market
8.2.6. Nordic Cholera vaccines Market
8.2.7. Benelux Cholera vaccines Market
8.2.8. Rest of Western Europe Cholera vaccines Market
8.3. Western Europe Cholera vaccines Market Size and Forecast, By Product
8.4. Western Europe Cholera vaccines Market Size and Forecast, By End User
8.5. Western Europe Cholera vaccines Market Attractiveness Index
8.6. Western Europe Cholera vaccines Market Attractiveness Index, By Country
8.7. Western Europe Cholera vaccines Market Attractiveness Index, By Product
8.8. Western Europe Cholera vaccines Market Attractiveness Index, By End User

9. Eastern Europe Cholera vaccines Market Analysis and Forecast, 2019-2029
9.1. Introduction
9.1.1. Eastern Europe Cholera vaccines Market
9.1.2. Eastern Europe Cholera vaccines Market, Annual Growth Rate Comparison, By Country
9.2. Eastern Europe Cholera vaccines Market Size and Forecast, By Country
9.2.1. Russia Cholera vaccines Market
9.2.2. Poland Cholera vaccines Market
9.2.3. Rest of Eastern Europe Cholera vaccines Market
9.3. Eastern Europe Cholera vaccines Market Size and Forecast, By Product
9.4. Eastern Europe Cholera vaccines Market Size and Forecast, By End User
9.5. Eastern Europe Cholera vaccines Market Attractiveness Index
9.6. Eastern Europe Cholera vaccines Market Attractiveness Index, By Country
9.7. Eastern Europe Cholera vaccines Market Attractiveness Index, By Product
9.8. Eastern Europe Cholera vaccines Market Attractiveness Index, By End User

10. Asia Pacific Cholera vaccines Market Analysis and Forecast, 2019-2029
10.1. Introduction
10.1.1. Asia Pacific Cholera vaccines Market
10.1.2. Asia Pacific Cholera vaccines Market, Annual Growth Rate Comparison, By Country
10.2. Asia Pacific Cholera vaccines Market Size and Forecast, By Country
10.2.1. China Cholera vaccines Market
10.2.2. India Cholera vaccines Market
10.2.3. Australia Cholera vaccines Market
10.2.4. ASEAN Cholera vaccines Market
10.2.5. Japan Cholera vaccines Market
10.2.6. Rest of Asia Pacific Cholera vaccines Market
10.3. Asia Pacific Cholera vaccines Market Size and Forecast, By Product
10.4. Asia Pacific Cholera vaccines Market Size and Forecast, By End User
10.5. Asia Pacific Cholera vaccines Market Attractiveness Index
10.6. Asia Pacific Cholera vaccines Market Attractiveness Index, By Country
10.7. Asia Pacific Cholera vaccines Market Attractiveness Index, By Product
10.8. Asia Pacific Cholera vaccines Market Attractiveness Index, By End User

11. MEA Cholera vaccines Market Analysis and Forecast, 2019-2029
11.1. Introduction
11.1.1. MEA Cholera vaccines Market
11.1.2. MEA Cholera vaccines Market, Annual Growth Rate Comparison, By Country
11.2. MEA Cholera vaccines Market Size and Forecast, By Country
11.2.1. GCC Cholera vaccines Market
11.2.2. South Africa Cholera vaccines Market
11.2.3. North Africa Cholera vaccines Market
11.2.4. Rest of MEA Cholera vaccines Market
11.3. MEA Cholera vaccines Market Size and Forecast, By Product
11.4. MEA Cholera vaccines Market Size and Forecast, By End User
11.5. MEA Cholera vaccines Market Attractiveness Index
11.6. MEA Cholera vaccines Market Attractiveness Index, By Country
11.7. MEA Cholera vaccines Market Attractiveness Index, By Product
11.8. MEA Cholera vaccines Market Attractiveness Index, By End User

12. Leading Companies in the Cholera vaccines Market
12.1. Competition Dashboard
12.2. Company Share Analysis
12.3. Company Profiling of 25 Major Players
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance (2016-2018)
12.3.4. Recent Initiatives
12.3.5. Average Gross Margin (2016-2018)

13. Conclusion

14. Glossary

List of Figures
15.1. Research design
15.2. Market segmentation & scope
15.3. Value chain analysis
15.4. Porter's Five Forces
15.5. Market summary
15.6. Market driver analysis (Current & Future Impact)
15.7. Market restraint analysis (Current & Future Impact)
15.8. Global Cholera vaccines Market by Product, 2019-2029 (USD million)
15.9. Global Cholera vaccines Market for Dukoral, 2019-2029 (USD million)
15.10. Global Cholera vaccines Market for Shanchol, 2019-2029 (USD million)
15.11. Global Cholera vaccines Market for Vaxchora, 2019-2029 (USD million)
15.12. Global Cholera vaccines Market for Euvichol & Euvichol-Plus, 2019-2029 (USD million)
15.13. Global Cholera vaccines Market for Others, 2019-2029 (USD million)
15.14. Global Cholera vaccines Market by End Users, 2019-2029 (USD million)
15.15. Global Cholera vaccines Market for Hospitals & Clinics, 2019-2029 (USD million)
15.16. Global Cholera vaccines Market for Academic & research laboratories,2019-2029 (USD million)
15.17. Global Cholera vaccines Market for Other End Users, 2019- 2029 (USD million)
15.18. North America Cholera vaccines Market by Product, 2019-2029 (USD million)
15.19. North America Cholera vaccines Market for Dukoral, 2019-2029 (USD million)
15.20. North America Cholera vaccines Market for Shanchol, 2019-2029 (USD million)
15.21. North America Cholera vaccines Market for Vaxchora, 2019-2029 (USD million)
15.22. North America Cholera vaccines Market for Euvichol & Euvichol-Plus, 2019-2029 (USD million)
15.23. North America Cholera vaccines Market for Others, 2019-2029 (USD million)
15.24. North America Cholera vaccines Market by End Users, 2019-2029 (USD million)
15.25. North America Cholera vaccines Market for Hospitals & Clinics, 2019-2029 (USD million)
15.26. North America Cholera vaccines Market for Academic & research laboratories,2019-2029 (USD million)
15.27. North America Cholera vaccines Market for Other End Users, 2019- 2029 (USD million)
15.28. Latin America Cholera vaccines Market by Product, 2019-2029 (USD million)
15.29. Latin America Cholera vaccines Market for Dukoral, 2019-2029 (USD million)
15.30. Latin America Cholera vaccines Market for Shanchol, 2019-2029 (USD million)
15.31. Latin America Cholera vaccines Market for Vaxchora, 2019-2029 (USD million)
15.32. Latin America Cholera vaccines Market for Euvichol & Euvichol-Plus, 2019-2029 (USD million)
15.33. Latin America Cholera vaccines Market for Others, 2019-2029 (USD million)
15.34. Latin America Cholera vaccines Market by End Users, 2019-2029 (USD million)
15.35. Latin America Cholera vaccines Market for Hospitals & Clinics, 2019-2029 (USD million)
15.36. Latin America Cholera vaccines Market for Academic & research laboratories,2019-2029 (USD million)
15.37. Latin America Cholera vaccines Market for Other End Users, 2019- 2029 (USD million)
15.38. Western Europe Cholera vaccines Market by Product, 2019-2029 (USD million)
15.39. Western Europe Cholera vaccines Market for Dukoral, 2019-2029 (USD million)
15.40. Western Europe Cholera vaccines Market for Shanchol, 2019-2029 (USD million)
15.41. Western Europe Cholera vaccines Market for Vaxchora, 2019-2029 (USD million)
15.42. Western Europe Cholera vaccines Market for Euvichol & Euvichol-Plus, 2019-2029 (USD million)
15.43. Western Europe Cholera vaccines Market for Others, 2019-2029 (USD million)
15.44. Western Europe Cholera vaccines Market by End Users, 2019-2029 (USD million)
15.45. Western Europe Cholera vaccines Market for Hospitals & Clinics, 2019-2029 (USD million)
15.46. Western Europe Cholera vaccines Market for Academic & research laboratories,2019-2029 (USD million)
15.47. Western Europe Cholera vaccines Market for Other End Users, 2019- 2029 (USD million)
15.48. Eastern Europe Cholera vaccines Market by Product, 2019-2029 (USD million)
15.49. Eastern Europe Cholera vaccines Market for Dukoral, 2019-2029 (USD million)
15.50. Eastern Europe Cholera vaccines Market for Shanchol, 2019-2029 (USD million)
15.51. Eastern Europe Cholera vaccines Market for Vaxchora, 2019-2029 (USD million)
15.52. Eastern Europe Cholera vaccines Market for Euvichol & Euvichol-Plus, 2019-2029 (USD million)
15.53. Eastern Europe Cholera vaccines Market for Others, 2019-2029 (USD million)
15.54. Eastern Europe Cholera vaccines Market by End Users, 2019-2029 (USD million)
15.55. Eastern Europe Cholera vaccines Market for Hospitals & Clinics, 2019-2029 (USD million)
15.56. Eastern Europe Cholera vaccines Market for Academic & research laboratories,2019-2029 (USD million)
15.57. Eastern Europe Cholera vaccines Market for Other End Users, 2019- 2029 (USD million)
15.58. Asia Pacific Cholera vaccines Market by Product, 2019-2029 (USD million)
15.59. Asia Pacific Cholera vaccines Market for Dukoral, 2019-2029 (USD million)
15.60. Asia Pacific Cholera vaccines Market for Shanchol, 2019-2029 (USD million)
15.61. Asia Pacific Cholera vaccines Market for Vaxchora, 2019-2029 (USD million)
15.62. Asia Pacific Cholera vaccines Market for Euvichol & Euvichol-Plus, 2019-2029 (USD million)
15.63. Asia Pacific Cholera vaccines Market for Others, 2019-2029 (USD million)
15.64. Asia Pacific Cholera vaccines Market by End Users, 2019-2029 (USD million)
15.65. Asia Pacific Cholera vaccines Market for Hospitals & Clinics, 2019-2029 (USD million)
15.66. Asia Pacific Cholera vaccines Market for Academic & research laboratories,2019-2029 (USD million)
15.67. Asia Pacific Cholera vaccines Market for Other End Users, 2019- 2029 (USD million)
15.68. MEA Cholera vaccines Market by Product, 2019-2029 (USD million)
15.69. MEA Cholera vaccines Market for Dukoral, 2019-2029 (USD million)
15.70. MEA Cholera vaccines Market for Shanchol, 2019-2029 (USD million)
15.71. MEA Cholera vaccines Market for Vaxchora, 2019-2029 (USD million)
15.72. MEA Cholera vaccines Market for Euvichol & Euvichol-Plus, 2019-2029 (USD million)
15.73. MEA Cholera vaccines Market for Others, 2019-2029 (USD million)
15.74. MEA Cholera vaccines Market by End Users, 2019-2029 (USD million)
15.75. MEA Cholera vaccines Market for Hospitals & Clinics, 2019-2029 (USD million)
15.76. MEA Cholera vaccines Market for Academic & research laboratories,2019-2029 (USD million)
15.77. MEA Cholera vaccines Market for Other End Users, 2019- 2029 (USD million)
15.78. List of Companies

List of Tables
16.1. Global Cholera vaccines Market, by Product, 2019-2029 (USD million)
16.2. Global Cholera vaccines Market, by End User, 2019-2029 (USD million)
16.3. North America Cholera vaccines Market, 2019-2029 (USD million)
16.4. U.S. Cholera vaccines Market, 2019-2029 (USD million)
16.5. Canada Cholera vaccines Market, 2019-2029 (USD million)
16.6. Latin America Cholera vaccines Market, 2019-2029 (USD million)
16.7. Brazil Cholera vaccines Market, 2019-2029 (USD million)
16.8. Mexico Cholera vaccines Market, 2019-2029 (USD million)
16.9. Rest of Latin America Cholera vaccines Market, 2019-2029 (USD million)
16.10. Western Europe Cholera vaccines Market, 2019-2029 (USD million)
16.11. UK Cholera vaccines Market, 2019-2029 (USD million)
16.12. France Cholera vaccines Market, 2019-2029 (USD million)
16.13. Germany Cholera vaccines Market, 2019-2029 (USD million)
16.14. Italy Cholera vaccines Market, 2019-2029 (USD million)
16.15. Nordic Cholera vaccines Market, 2019-2029 (USD million)
16.16. Benelux Cholera vaccines Market, 2019-2029 (USD million)
16.17. Rest of Western Europe Cholera vaccines Market, 2019-2029 (USD million)
16.18. Eastern Europe Cholera vaccines Market, 2019-2029 (USD million)
16.19. Russia Cholera vaccines Market, 2019-2029 (USD million)
16.20. Poland Cholera vaccines Market, 2019-2029 (USD million)
16.21. Rest of Eastern Europe Cholera vaccines Market, 2019-2029 (USD million)
16.22. Asia Pacific Cholera vaccines Market, 2019-2029 (USD million)
16.23. Japan Cholera vaccines Market, 2019-2029 (USD million)
16.24. India Cholera vaccines Market, 2019-2029 (USD million)
16.25. Australia Cholera vaccines Market, 2019-2029 (USD million)
16.26. ASEAN Cholera vaccines Market, 2019-2029 (USD million)
16.27. China Cholera vaccines Market, 2019-2029 (USD million)
16.28. Rest of Asia Pacific Cholera vaccines Market, 2019-2029 (USD million)
16.29. MEA Cholera vaccines Market, 2019-2029 (USD million)
16.30. South Africa Cholera vaccines Market, 2019-2029 (USD million)
16.31. North Africa Cholera vaccines Market, 2019-2029 (USD million)
16.32. GCC Cholera vaccines Market, 2019-2029 (USD million)
16.33. Rest of MEA Cholera vaccines Market, 2019-2029 (USD million)

Astellas Pharma Inc.
AstraZeneca
Celldex Therapeutics, Inc.
Emergent BioSolutions Inc.
Eubiologics Co., Ltd.
GlaxoSmithKline plc (GSK)
Johnson & Johnson (Crucell)
Merck & Co. Inc.
Mitsubishi Tanabe Pharma Corporation
PaxVax Inc.
Pfizer Inc.
Shantha Biotechnics Private Limited
Takeda Pharmaceutical Co. Ltd